Araştırma Makalesi

Inflammatory and Metabolic Markers in Stroke: Diagnostic and Prognostic Associations of NLR and GPR

Cilt: 48 Sayı: 3 12 Mayıs 2026
PDF İndir
TR EN

Inflammatory and Metabolic Markers in Stroke: Diagnostic and Prognostic Associations of NLR and GPR

Öz

The neutrophil-to-lymphocyte ratio (NLR) and glucose-to-potassium ratio (GPR) are simple, readily available markers reflecting inflammatory and metabolic responses in acute stroke. However, their diagnostic value in emergency department (ED) presentations remains uncertain. This study evaluated the association of NLR and GPR with stroke among patients presenting with stroke-like symptoms. This retrospective study included 475 participants (286 stroke, 189 controls). Demographic, clinical, and laboratory data were analyzed. Independent predictors were identified using multivariable logistic regression, and diagnostic performance was assessed with receiver operating characteristic (ROC) analysis. Stroke patients were older than controls (59 vs. 43 years, p<0.001) and had higher prevalences of hypertension, diabetes mellitus, and coronary artery disease (all p<0.05). NLR, GPR, and C-reactive protein levels were higher (all p<0.001), while lymphocyte counts (p=0.015) and albumin levels (p=0.018) were lower. Age was an independent predictor of both ischemic and hemorrhagic stroke (p<0.001). GPR was independently associated with ischemic stroke (OR=1.08, 95% CI: 1.05–1.12, p<0.001). In hemorrhagic stroke, both NLR (OR=1.40, 95% CI: 1.20–1.65, p<0.001) and GPR (OR=1.13, 95% CI: 1.06–1.21, p<0.001) remained significant. Hypertension showed the strongest association with hemorrhagic stroke (p<0.001). ROC analysis demonstrated moderate discrimination (AUC: 0.636 for NLR; 0.729 for GPR). NLR and GPR were elevated in stroke and showed moderate diagnostic performance. GPR was associated with ischemic stroke, whereas both markers were linked to hemorrhagic stroke, suggesting complementary pathophysiological roles.

Anahtar Kelimeler

Destekleyen Kurum

yok

Etik Beyan

Necmettin Erbakan Üniversitesi Etik Kurulu onayının (Onay numarası: 2025/5535) ardından hasta dosyalarının retrospektif değerlendirmesi yapıldı.

Teşekkür

yok

Kaynakça

  1. 1. Feigin VL, Norrving B, Mensah GA. Global Burden of Stroke. Circ Res. 2017;120(3):439-48.
  2. 2. Global, regional, and national burden of stroke, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 2019;18(5):439-58.
  3. 3. Donnan GA, Fisher M, Macleod M, Davis SM. Stroke. Lancet. 2008;371(9624):1612-23.
  4. 4. Virani SS, Alonso A, Aparicio HJ, Benjamin EJ, Bittencourt MS, Callaway CW, et al. Heart Disease and Stroke Statistics-2021 Update: A Report From the American Heart Association. Circulation. 2021;143(8):e254-e743.
  5. 5. Campbell BCV, De Silva DA, Macleod MR, Coutts SB, Schwamm LH, Davis SM, et al. Ischaemic stroke. Nat Rev Dis Primers. 2019;5(1):70. 6. Murphy SJ, Werring DJ. Stroke: causes and clinical features. Medicine (Abingdon). 2020;48(9):561-6.
  6. 7. van Asch CJ, Luitse MJ, Rinkel GJ, van der Tweel I, Algra A, Klijn CJ. Incidence, case fatality, and functional outcome of intracerebral haemorrhage over time, according to age, sex, and ethnic origin: a systematic review and meta-analysis. Lancet Neurol. 2010;9(2):167-76.
  7. 8. Kelly PJ, Lemmens R, Tsivgoulis G. Inflammation and Stroke Risk: A New Target for Prevention. Stroke. 2021;52(8):2697-706.
  8. 9. Dirnagl U, Klehmet J, Braun JS, Harms H, Meisel C, Ziemssen T, et al. Stroke-induced immunodepression: experimental evidence and clinical relevance. Stroke. 2007;38(2 Suppl):770-3.

Ayrıntılar

Birincil Dil

İngilizce

Konular

Acil Tıp, Nöroloji ve Nöromüsküler Hastalıklar

Bölüm

Araştırma Makalesi

Yayımlanma Tarihi

12 Mayıs 2026

Gönderilme Tarihi

7 Ekim 2025

Kabul Tarihi

3 Mart 2026

Yayımlandığı Sayı

Yıl 2026 Cilt: 48 Sayı: 3

Kaynak Göster

APA
Kenan, N., Doğan, E., Çap, A. M., Kadıoğlu, E., Yılmaz, Y., & Acar, D. (2026). Inflammatory and Metabolic Markers in Stroke: Diagnostic and Prognostic Associations of NLR and GPR. Osmangazi Tıp Dergisi, 48(3), 514-523. https://doi.org/10.20515/otd.1798641
AMA
1.Kenan N, Doğan E, Çap AM, Kadıoğlu E, Yılmaz Y, Acar D. Inflammatory and Metabolic Markers in Stroke: Diagnostic and Prognostic Associations of NLR and GPR. Osmangazi Tıp Dergisi. 2026;48(3):514-523. doi:10.20515/otd.1798641
Chicago
Kenan, Nazlı, Emine Doğan, Asiye Müminat Çap, Emine Kadıoğlu, Yavuz Yılmaz, ve Demet Acar. 2026. “Inflammatory and Metabolic Markers in Stroke: Diagnostic and Prognostic Associations of NLR and GPR”. Osmangazi Tıp Dergisi 48 (3): 514-23. https://doi.org/10.20515/otd.1798641.
EndNote
Kenan N, Doğan E, Çap AM, Kadıoğlu E, Yılmaz Y, Acar D (01 Mayıs 2026) Inflammatory and Metabolic Markers in Stroke: Diagnostic and Prognostic Associations of NLR and GPR. Osmangazi Tıp Dergisi 48 3 514–523.
IEEE
[1]N. Kenan, E. Doğan, A. M. Çap, E. Kadıoğlu, Y. Yılmaz, ve D. Acar, “Inflammatory and Metabolic Markers in Stroke: Diagnostic and Prognostic Associations of NLR and GPR”, Osmangazi Tıp Dergisi, c. 48, sy 3, ss. 514–523, May. 2026, doi: 10.20515/otd.1798641.
ISNAD
Kenan, Nazlı - Doğan, Emine - Çap, Asiye Müminat - Kadıoğlu, Emine - Yılmaz, Yavuz - Acar, Demet. “Inflammatory and Metabolic Markers in Stroke: Diagnostic and Prognostic Associations of NLR and GPR”. Osmangazi Tıp Dergisi 48/3 (01 Mayıs 2026): 514-523. https://doi.org/10.20515/otd.1798641.
JAMA
1.Kenan N, Doğan E, Çap AM, Kadıoğlu E, Yılmaz Y, Acar D. Inflammatory and Metabolic Markers in Stroke: Diagnostic and Prognostic Associations of NLR and GPR. Osmangazi Tıp Dergisi. 2026;48:514–523.
MLA
Kenan, Nazlı, vd. “Inflammatory and Metabolic Markers in Stroke: Diagnostic and Prognostic Associations of NLR and GPR”. Osmangazi Tıp Dergisi, c. 48, sy 3, Mayıs 2026, ss. 514-23, doi:10.20515/otd.1798641.
Vancouver
1.Nazlı Kenan, Emine Doğan, Asiye Müminat Çap, Emine Kadıoğlu, Yavuz Yılmaz, Demet Acar. Inflammatory and Metabolic Markers in Stroke: Diagnostic and Prognostic Associations of NLR and GPR. Osmangazi Tıp Dergisi. 01 Mayıs 2026;48(3):514-23. doi:10.20515/otd.1798641


13299        13308       13306       13305    13307  1330126978